Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹124 Cr₹132 Cr₹404 Cr₹310 Cr₹222 Cr

What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS is ₹124 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹124 Cr
Mar2024₹132 Cr
Mar2023₹404 Cr
Mar2022₹310 Cr
Mar2021₹222 Cr

How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹124 Cr
-6.26
Mar2024 ₹132 Cr
-67.20
Mar2023 ₹404 Cr
30.25
Mar2022 ₹310 Cr
39.81
Mar2021 ₹222 Cr -

Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,350.2 Cr 3.1% 5.3% 55% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.1%

5.3%

55%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses